US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Inhibikase Therapeutics, Inc.

2.38

+0.06502.81%

Volume:145.41K

Turnover:336.68K

Market Cap:332.50M

PE:-5.49

High:2.38

Open:2.30

Low:2.27

Close:2.31

52wk High:2.54

52wk Low:1.33

Shares:140.00M

Float Shares:64.52M

Volume Ratio:1.50

T/O Rate:0.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4327

EPS(LYR):-0.4909

ROE:-51.96%

ROA:-32.79%

PB:2.17

PE(LYR):-4.84

Loading ...

Overview Company News Filings

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Inhibikase Shareholders Approve Governance and Compensation Changes

Inhibikase Therapeutics Holds Annual Shareholder Meeting

Inhibikase Therapeutics Inc : Oppenheimer Initiates Coverage With Outperform Rating and Target Price $5

THOMSON REUTERS

Inhibikase Therapeutics initiated with an Outperform at Oppenheimer

Oppenheimer Initiates Inhibikase Therapeutics at Outperform

MT Newswires Live

Inhibikase Therapeutics: Buy Rating Reiterated on Advancing Phase 3 PAH Program and Robust IP, Price Target Maintained at $8

LifeSci Capital Keeps Their Buy Rating on Inhibikase Therapeutics (IKT)

Analysts Are Bullish on These Healthcare Stocks: Milestone Scientific (MLSS), Inhibikase Therapeutics (IKT)

Inhibikase Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Inhibikase Therapeutics Q1 EPS $(0.10) Beats $(0.13) Estimate

Benzinga Earnings

Inhibikase Therapeutics Announces First Quarter 2026 Financial Results and Highlights Recent Activity

THOMSON REUTERS

Inhibikase Advances IKT-001 Into Adaptive Phase 3 Trial for Pulmonary Arterial Hypertension

Inhibikase Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview

Inhibikase Therapeutics announces annual shareholder meeting webcast

Buy Rating on IKT-001: De-Risked Late-Stage PAH Program with Adaptive Phase 3 Design and Solid Financial Runway

Inhibikase Therapeutics: Phase 3 IKT-001 PAH Program and De-Risked Imatinib-Based Efficacy Drive Buy Rating and $8 Target

Inhibikase Begins Pivotal Phase 3 Trial in PAH

Inhibikase enrolls first patient in Phase 3 IMPROVE-PAH trial for IKT-001

Inhibikase Therapeutics Announces Enrollment of First Patient in Improve-Pah Global Phase 3 Study of Ikt-001 in the Treatment of Pulmonary Arterial Hypertension

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/IKT/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IKT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IKT\",,,,,undefined,":{"symbol":"IKT","market":"US","secType":"STK","nameCN":"Inhibikase Therapeutics, Inc.","latestPrice":2.375,"timestamp":1788276749228,"preClose":2.31,"halted":0,"volume":145410,"delay":0,"changeRate":0.028138528138528116,"floatShares":64520500,"shares":140000000,"eps":-0.432671,"marketStatus":"Trading","change":0.065,"latestTime":"09-01 11:32:30 EDT","open":2.3,"high":2.38,"low":2.27,"amount":336676.4976,"amplitude":0.047619,"askPrice":2.38,"askSize":400,"bidPrice":2.37,"bidSize":3776,"shortable":3,"etf":0,"ttmEps":-0.432671,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"listingDate":1608699600000,"exchange":"NASDAQ","adjPreClose":2.31,"preHourTrading":{"tag":"盘前","latestPrice":2.31,"preClose":2.31,"latestTime":"09:26 EDT","volume":42542,"amount":98271.6030884,"timestamp":1788269178432,"change":0,"changeRate":0,"amplitude":0.011948},"postHourTrading":{"tag":"盘后","latestPrice":2.31,"preClose":2.31,"latestTime":"19:30 EDT","volume":1205,"amount":2782.95,"timestamp":1788219002852,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.498831},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IKT\",,,,,undefined,":{"symbol":"IKT","floatShares":64520500,"roa":"-32.79%","roe":"-51.96%","lyrEps":-0.490886,"volumeRatio":1.498831,"shares":140000000,"dividePrice":0,"high":2.38,"amplitude":0.047619,"preClose":2.31,"low":2.27,"week52Low":1.33,"pbRate":"2.17","psRate":"332500000.00","week52High":2.54,"institutionHeld":0,"latestPrice":2.375,"committee":0.808429,"eps":-0.432671,"divideRate":0,"volume":145410,"delay":0,"ttmEps":-0.432671,"open":2.3,"prevYearClose":2.05,"prevWeekClose":2.41,"prevMonthClose":2.31,"prevQuarterClose":2.03,"fiveDayClose":2.5,"twentyDayClose":2.44,"sixtyDayClose":1.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IKT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"IKT","fiscalQuarterEnding":"2026/06","expectedEps":-0.09,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2026-05-12","symbol":"IKT","fiscalQuarterEnding":"2026/03","expectedEps":-0.1,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2026-03-26","symbol":"IKT","fiscalQuarterEnding":"2025/12","expectedEps":-0.12,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-0.09},{"market":"US","date":"2025-11-14","symbol":"IKT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-14","symbol":"IKT","fiscalQuarterEnding":"2025/06","expectedEps":-0.09,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IKT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IKT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.5556,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1784174400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IKT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IKT","date":"2026-08-31","current":-5.489159,"percent":0.11093,"low":-13.634097,"twenty":-5.918521,"median":-2.183855,"eighty":-0.714693,"high":-0.227656,"avg":-3.184234,"sd":2.888242,"marketCap":438800292},"quantilePoints":[{"date":"2021-09-03","current":-8.469349,"twenty":-35.46585,"median":-19.657764,"eighty":-11.488131,"marketCap":60571361},{"date":"2021-09-10","current":-8.047639,"twenty":-35.446427,"median":-19.357452,"eighty":-11.178507,"marketCap":57555360},{"date":"2021-09-17","current":-7.169075,"twenty":-35.388159,"median":-19.146027,"eighty":-10.964452,"marketCap":51272023},{"date":"2021-09-24","current":-7.133933,"twenty":-35.261911,"median":-18.972776,"eighty":-10.790222,"marketCap":51020690},{"date":"2021-10-01","current":-6.81765,"twenty":-35.203643,"median":-18.63429,"eighty":-10.097489,"marketCap":48758689},{"date":"2021-10-08","current":-6.466225,"twenty":-35.106529,"median":-18.474357,"eighty":-9.686832,"marketCap":46245354},{"date":"2021-10-15","current":-6.782508,"twenty":-34.902591,"median":-18.324861,"eighty":-9.266226,"marketCap":48507355},{"date":"2021-10-22","current":-6.53651,"twenty":-34.795766,"median":-18.121119,"eighty":-8.483406,"marketCap":46748021},{"date":"2021-10-29","current":-6.993363,"twenty":-34.766632,"median":-17.530327,"eighty":-8.183189,"marketCap":50015356},{"date":"2021-11-05","current":-7.590786,"twenty":-34.74721,"median":-15.525339,"eighty":-7.801641,"marketCap":54288025},{"date":"2021-11-12","current":-7.063648,"twenty":-34.60154,"median":-14.812701,"eighty":-7.604843,"marketCap":50518023},{"date":"2021-11-19","current":-4.36386,"twenty":-34.349044,"median":-14.761798,"eighty":-7.464273,"marketCap":47794876},{"date":"2021-11-26","current":-4.731343,"twenty":-34.213182,"median":-14.710895,"eighty":-7.344788,"marketCap":51819707},{"date":"2021-12-03","current":-3.789668,"twenty":-34.106649,"median":-14.380027,"eighty":-7.204218,"marketCap":41506076},{"date":"2021-12-10","current":-3.835604,"twenty":-33.95088,"median":-14.25277,"eighty":-7.140961,"marketCap":42009180},{"date":"2021-12-17","current":-3.743733,"twenty":-33.776075,"median":-13.845548,"eighty":-7.035534,"marketCap":41002972},{"date":"2021-12-23","current":-3.605927,"twenty":-33.698384,"median":-13.565583,"eighty":-6.95822,"marketCap":39493660},{"date":"2021-12-31","current":-3.37625,"twenty":-33.504157,"median":-13.13291,"eighty":-6.81765,"marketCap":36978141},{"date":"2022-01-07","current":-3.330315,"twenty":-33.212817,"median":-12.587222,"eighty":-6.747365,"marketCap":36475037},{"date":"2022-01-14","current":-3.835604,"twenty":-33.115703,"median":-12.420271,"eighty":-6.67708,"marketCap":42009180},{"date":"2022-01-21","current":-3.034368,"twenty":-32.688404,"median":-12.223376,"eighty":-6.641938,"marketCap":33233707},{"date":"2022-01-28","current":-2.873455,"twenty":-32.542733,"median":-12.140306,"eighty":-6.53651,"marketCap":31471313},{"date":"2022-02-04","current":-2.988393,"twenty":-32.533022,"median":-11.857835,"eighty":-6.34674,"marketCap":32730166},{"date":"2022-02-11","current":-2.873685,"twenty":-32.533022,"median":-11.660488,"eighty":-5.898377,"marketCap":31473831},{"date":"2022-02-18","current":-2.52864,"twenty":-32.494176,"median":-11.554924,"eighty":-4.667034,"marketCap":27694756},{"date":"2022-02-25","current":-2.482665,"twenty":-32.397063,"median":-11.453119,"eighty":-4.405202,"marketCap":27191215},{"date":"2022-03-04","current":-2.505653,"twenty":-32.251393,"median":-11.181857,"eighty":-4.203087,"marketCap":27442985},{"date":"2022-03-11","current":-3.172294,"twenty":-32.105723,"median":-10.994994,"eighty":-3.922881,"marketCap":34744330},{"date":"2022-03-18","current":-3.31022,"twenty":-31.930919,"median":-10.942542,"eighty":-3.835604,"marketCap":36254953},{"date":"2022-03-25","current":-3.195282,"twenty":-31.824094,"median":-10.900243,"eighty":-3.780481,"marketCap":34996100},{"date":"2022-04-01","current":-2.456837,"twenty":-31.746403,"median":-10.503575,"eighty":-3.734546,"marketCap":36326953},{"date":"2022-04-08","current":-2.345939,"twenty":-31.707557,"median":-9.974245,"eighty":-3.67483,"marketCap":34687195},{"date":"2022-04-14","current":-2.166794,"twenty":-31.493907,"median":-9.722425,"eighty":-3.578365,"marketCap":32038354},{"date":"2022-04-22","current":-2.056919,"twenty":-31.115165,"median":-9.677786,"eighty":-3.445153,"marketCap":30413732},{"date":"2022-04-29","current":-1.842628,"twenty":-30.988917,"median":-9.351798,"eighty":-3.386618,"marketCap":27245215},{"date":"2022-05-06","current":-1.629361,"twenty":-30.814113,"median":-8.539634,"eighty":-3.318258,"marketCap":24091833},{"date":"2022-05-13","current":-1.143112,"twenty":-30.639309,"median":-8.469349,"eighty":-3.287232,"marketCap":16902124},{"date":"2022-05-20","current":-0.985967,"twenty":-30.445082,"median":-8.287361,"eighty":-3.218269,"marketCap":16553990},{"date":"2022-05-27","current":-1.406378,"twenty":-29.998359,"median":-8.047639,"eighty":-3.181489,"marketCap":23612519},{"date":"2022-06-03","current":-1.420051,"twenty":-29.590483,"median":-7.801641,"eighty":-3.153354,"marketCap":23842085},{"date":"2022-06-10","current":-1.427414,"twenty":-28.77473,"median":-7.696213,"eighty":-3.080344,"marketCap":23965698},{"date":"2022-06-17","current":-1.30721,"twenty":-28.26974,"median":-7.590786,"eighty":-3.015978,"marketCap":21947534},{"date":"2022-06-24","current":-1.223369,"twenty":-28.114358,"median":-7.590786,"eighty":-2.965405,"marketCap":20539864},{"date":"2022-07-01","current":-1.141931,"twenty":-28.114358,"median":-7.415074,"eighty":-2.873455,"marketCap":19172558},{"date":"2022-07-08","current":-1.300148,"twenty":-27.803595,"median":-7.344788,"eighty":-2.834376,"marketCap":21828967},{"date":"2022-07-15","current":-1.265289,"twenty":-27.531677,"median":-7.309646,"eighty":-2.58381,"marketCap":21243699},{"date":"2022-07-22","current":-1.367162,"twenty":-27.366584,"median":-7.186647,"eighty":-2.501055,"marketCap":22954093},{"date":"2022-07-29","current":-1.277008,"twenty":-27.143223,"median":-7.169075,"eighty":-2.43669,"marketCap":21440445},{"date":"2022-08-05","current":-1.217058,"twenty":-26.97813,"median":-7.09879,"eighty":-2.384419,"marketCap":20433911},{"date":"2022-08-12","current":-1.242066,"twenty":-25.628252,"median":-7.028505,"eighty":-2.286224,"marketCap":23342590},{"date":"2022-08-19","current":-1.013332,"twenty":-25.25922,"median":-6.975791,"eighty":-2.159969,"marketCap":19043900},{"date":"2022-08-26","current":-1.293612,"twenty":-22.639542,"median":-6.852793,"eighty":-2.051596,"marketCap":24311309},{"date":"2022-09-02","current":-1.246764,"twenty":-21.394141,"median":-6.81765,"eighty":-1.900637,"marketCap":23430884},{"date":"2022-09-09","current":-1.234683,"twenty":-21.224739,"median":-6.782508,"eighty":-1.842628,"marketCap":23203841},{"date":"2022-09-16","current":-1.369186,"twenty":-21.104745,"median":-6.747365,"eighty":-1.646763,"marketCap":25731592},{"date":"2022-09-23","current":-1.140988,"twenty":-20.970635,"median":-6.67708,"eighty":-1.511556,"marketCap":21442993},{"date":"2022-09-30","current":-1.221528,"twenty":-20.843583,"median":-6.67708,"eighty":-1.424469,"marketCap":22956616},{"date":"2022-10-07","current":-1.181258,"twenty":-20.617712,"median":-6.589224,"eighty":-1.382337,"marketCap":22199804},{"date":"2022-10-14","current":-1.110248,"twenty":-20.187147,"median":-6.53651,"eighty":-1.368376,"marketCap":20865293},{"date":"2022-10-21","current":-1.087429,"twenty":-19.890693,"median":-6.431083,"eighty":-1.350664,"marketCap":20436434},{"date":"2022-10-28","current":-1.042595,"twenty":-19.791875,"median":-6.290512,"eighty":-1.332174,"marketCap":19593850},{"date":"2022-11-04","current":-1.033601,"twenty":-19.700115,"median":-6.149942,"eighty":-1.309645,"marketCap":19424829},{"date":"2022-11-11","current":-0.671169,"twenty":-19.636589,"median":-4.731343,"eighty":-1.299367,"marketCap":12613525},{"date":"2022-11-18","current":-0.96515,"twenty":-19.46346,"median":-4.639473,"eighty":-1.293041,"marketCap":18160954},{"date":"2022-11-25","current":-0.898116,"twenty":-19.27994,"median":-4.490183,"eighty":-1.285241,"marketCap":16899601},{"date":"2022-12-02","current":-0.76968,"twenty":-19.163673,"median":-4.340893,"eighty":-1.27716,"marketCap":14482849},{"date":"2022-12-09","current":-0.656929,"twenty":-19.149556,"median":-4.191603,"eighty":-1.274845,"marketCap":12361254},{"date":"2022-12-16","current":-0.729996,"twenty":-19.106973,"median":-4.06528,"eighty":-1.265289,"marketCap":13736129},{"date":"2022-12-23","current":-0.663566,"twenty":-19.034028,"median":-3.870055,"eighty":-1.259005,"marketCap":12486128},{"date":"2022-12-30","current":-0.670336,"twenty":-18.950805,"median":-3.847087,"eighty":-1.245737,"marketCap":12613525},{"date":"2023-01-06","current":-0.742598,"twenty":-18.862919,"median":-3.835604,"eighty":-1.232083,"marketCap":13973263},{"date":"2023-01-13","current":-0.804403,"twenty":-18.740167,"median":-3.789668,"eighty":-1.221528,"marketCap":15136230},{"date":"2023-01-20","current":-0.911791,"twenty":-18.570764,"median":-3.766701,"eighty":-1.213608,"marketCap":17156917},{"date":"2023-01-27","current":-0.980103,"twenty":-18.500179,"median":-3.732249,"eighty":-1.20689,"marketCap":18442318},{"date":"2023-02-03","current":-1.14529,"twenty":-18.47811,"median":-3.67483,"eighty":-1.199756,"marketCap":21550606},{"date":"2023-02-10","current":-1.084965,"twenty":-18.472379,"median":-3.67483,"eighty":-1.186663,"marketCap":20415478},{"date":"2023-02-17","current":-1.132033,"twenty":-18.360826,"median":-3.559991,"eighty":-1.181258,"marketCap":21301158},{"date":"2023-02-24","current":-1.06426,"twenty":-18.323221,"median":-3.468121,"eighty":-1.174956,"marketCap":20025891},{"date":"2023-03-03","current":-1.087348,"twenty":-18.284112,"median":-3.433669,"eighty":-1.154787,"marketCap":20460323},{"date":"2023-03-10","current":-0.988593,"twenty":-18.177637,"median":-3.402171,"eighty":-1.144419,"marketCap":18602077},{"date":"2023-03-17","current":-0.968186,"twenty":-18.111392,"median":-3.356195,"eighty":-1.141554,"marketCap":18218096},{"date":"2023-03-24","current":-1.072453,"twenty":-17.893153,"median":-3.31022,"eighty":-1.133379,"marketCap":20180044},{"date":"2023-03-31","current":-0.979507,"twenty":-17.485996,"median":-3.287232,"eighty":-1.127007,"marketCap":18431107},{"date":"2023-04-06","current":-0.962818,"twenty":-16.870655,"median":-3.275739,"eighty":-1.115257,"marketCap":17382866},{"date":"2023-04-14","current":-0.90041,"twenty":-15.938315,"median":-3.218269,"eighty":-1.110039,"marketCap":16256147},{"date":"2023-04-21","current":-0.979061,"twenty":-15.301367,"median":-3.195282,"eighty":-1.10135,"marketCap":17676115},{"date":"2023-04-28","current":-0.847449,"twenty":-14.924687,"median":-3.172294,"eighty":-1.087348,"marketCap":15299981},{"date":"2023-05-05","current":-0.908841,"twenty":-14.822881,"median":-3.159424,"eighty":-1.080973,"marketCap":16408361},{"date":"2023-05-12","current":-1.06513,"twenty":-14.761798,"median":-3.103331,"eighty":-1.075133,"marketCap":19230022},{"date":"2023-05-19","current":-1.087321,"twenty":-14.761798,"median":-3.06885,"eighty":-1.075133,"marketCap":19453627},{"date":"2023-05-26","current":-1.054688,"twenty":-14.741437,"median":-3.034368,"eighty":-1.075133,"marketCap":18869770},{"date":"2023-06-02","current":-1.224972,"twenty":-14.710895,"median":-2.988393,"eighty":-1.075106,"marketCap":21916387},{"date":"2023-06-09","current":-1.203101,"twenty":-14.690534,"median":-2.930924,"eighty":-1.075508,"marketCap":21525078},{"date":"2023-06-16","current":-1.09357,"twenty":-14.578547,"median":-2.873455,"eighty":-1.077034,"marketCap":19565429},{"date":"2023-06-23","current":-1.138702,"twenty":-14.456381,"median":-2.873455,"eighty":-1.075079,"marketCap":20372892},{"date":"2023-06-30","current":-1.058854,"twenty":-14.334215,"median":-2.850467,"eighty":-1.074596,"marketCap":18944301},{"date":"2023-07-07","current":-0.807159,"twenty":-14.273131,"median":-2.758517,"eighty":-1.071179,"marketCap":14441151},{"date":"2023-07-14","current":-0.856341,"twenty":-14.25277,"median":-2.563122,"eighty":-1.065502,"marketCap":15321078},{"date":"2023-07-21","current":-0.815838,"twenty":-14.25277,"median":-2.505653,"eighty":-1.060533,"marketCap":14596432},{"date":"2023-07-28","current":-0.720368,"twenty":-14.008437,"median":-2.471171,"eighty":-1.056231,"marketCap":12888339},{"date":"2023-08-04","current":-0.73194,"twenty":-13.845548,"median":-2.43669,"eighty":-1.052021,"marketCap":13095381},{"date":"2023-08-11","current":-0.723261,"twenty":-13.784465,"median":-2.401147,"eighty":-1.049135,"marketCap":12940100},{"date":"2023-08-18","current":-0.649241,"twenty":-13.529951,"median":-2.367727,"eighty":-1.042635,"marketCap":12354633},{"date":"2023-08-25","current":-0.59584,"twenty":-13.356881,"median":-2.324612,"eighty":-1.037749,"marketCap":11338451},{"date":"2023-09-01","current":-0.564924,"twenty":-13.214354,"median":-2.200917,"eighty":-1.03213,"marketCap":10750135},{"date":"2023-09-08","current":-0.576166,"twenty":-13.031104,"median":-2.166794,"eighty":-1.02724,"marketCap":10964068},{"date":"2023-09-15","current":-0.472175,"twenty":-12.77659,"median":-2.081488,"eighty":-1.013056,"marketCap":8985187},{"date":"2023-09-22","current":-0.351321,"twenty":-12.594554,"median":-2.030303,"eighty":-1.006224,"marketCap":6685407},{"date":"2023-09-29","current":-0.404721,"twenty":-12.498445,"median":-1.927935,"eighty":-0.982895,"marketCap":7701589},{"date":"2023-10-06","current":-0.252951,"twenty":-12.420271,"median":-1.859689,"eighty":-0.979239,"marketCap":4813493},{"date":"2023-10-13","current":-0.259078,"twenty":-12.379549,"median":-1.842628,"eighty":-0.960141,"marketCap":4930086},{"date":"2023-10-20","current":-0.261383,"twenty":-12.280429,"median":-1.658365,"eighty":-0.935074,"marketCap":4973943},{"date":"2023-10-27","current":-0.236087,"twenty":-12.242394,"median":-1.629361,"eighty":-0.931552,"marketCap":4492593},{"date":"2023-11-03","current":-0.303541,"twenty":-12.218003,"median":-1.525079,"eighty":-0.924262,"marketCap":5776192},{"date":"2023-11-10","current":-0.281057,"twenty":-12.21666,"median":-1.489996,"eighty":-0.908627,"marketCap":5348326},{"date":"2023-11-17","current":-0.265599,"twenty":-12.094494,"median":-1.423732,"eighty":-0.89787,"marketCap":5080909},{"date":"2023-11-24","current":-0.280796,"twenty":-11.941785,"median":-1.401194,"eighty":-0.889896,"marketCap":5371623},{"date":"2023-12-01","current":-0.302582,"twenty":-11.858837,"median":-1.382337,"eighty":-0.877765,"marketCap":5788387},{"date":"2023-12-08","current":-0.374394,"twenty":-11.833386,"median":-1.372606,"eighty":-0.865483,"marketCap":7162164},{"date":"2023-12-15","current":-0.422808,"twenty":-11.751414,"median":-1.358146,"eighty":-0.857354,"marketCap":8088306},{"date":"2023-12-22","current":-0.40667,"twenty":-11.688774,"median":-1.354024,"eighty":-0.853448,"marketCap":7779592},{"date":"2023-12-29","current":-0.39376,"twenty":-11.651059,"median":-1.350259,"eighty":-0.851677,"marketCap":7532621},{"date":"2024-01-05","current":-0.43249,"twenty":-11.61184,"median":-1.341619,"eighty":-0.846797,"marketCap":8273535},{"date":"2024-01-12","current":-0.4454,"twenty":-11.595646,"median":-1.331653,"eighty":-0.830808,"marketCap":8520506},{"date":"2024-01-19","current":-0.561592,"twenty":-11.554924,"median":-1.318029,"eighty":-0.815838,"marketCap":10743247},{"date":"2024-01-26","current":-0.793974,"twenty":-11.511472,"median":-1.307438,"eighty":-0.804403,"marketCap":15188728},{"date":"2024-02-02","current":-0.876363,"twenty":-11.453119,"median":-1.299848,"eighty":-0.807159,"marketCap":16764818},{"date":"2024-02-09","current":-0.889298,"twenty":-11.198605,"median":-1.296664,"eighty":-0.811375,"marketCap":17012270},{"date":"2024-02-16","current":-0.766413,"twenty":-11.198605,"median":-1.292898,"eighty":-0.807159,"marketCap":14661483},{"date":"2024-02-23","current":-0.704971,"twenty":-11.171808,"median":-1.287142,"eighty":-0.801128,"marketCap":13486090},{"date":"2024-03-01","current":-0.698503,"twenty":-11.110462,"median":-1.27746,"eighty":-0.787359,"marketCap":13362364},{"date":"2024-03-08","current":-0.782582,"twenty":-11.015355,"median":-1.27716,"eighty":-0.775336,"marketCap":14970797},{"date":"2024-03-15","current":-0.688802,"twenty":-10.994994,"median":-1.277009,"eighty":-0.769673,"marketCap":13176776},{"date":"2024-03-22","current":-0.714672,"twenty":-10.954272,"median":-1.271628,"eighty":-0.760981,"marketCap":13671678},{"date":"2024-03-28","current":-0.747729,"twenty":-10.942232,"median":-1.267168,"eighty":-0.74613,"marketCap":14228444},{"date":"2024-04-05","current":-0.748812,"twenty":-10.916543,"median":-1.262134,"eighty":-0.740589,"marketCap":14249056},{"date":"2024-04-12","current":-0.765831,"twenty":-10.900243,"median":-1.2595,"eighty":-0.739435,"marketCap":14572899},{"date":"2024-04-19","current":-0.714775,"twenty":-10.790222,"median":-1.249968,"eighty":-0.736464,"marketCap":13601372},{"date":"2024-04-26","current":-0.646701,"twenty":-10.669955,"median":-1.243773,"eighty":-0.73194,"marketCap":12306003},{"date":"2024-05-03","current":-0.456095,"twenty":-10.476555,"median":-1.234346,"eighty":-0.731794,"marketCap":8678970},{"date":"2024-05-10","current":-0.462902,"twenty":-10.316803,"median":-1.227143,"eighty":-0.728471,"marketCap":8808507},{"date":"2024-05-17","current":-0.593688,"twenty":-10.097489,"median":-1.223369,"eighty":-0.724986,"marketCap":11399245},{"date":"2024-05-24","current":-0.685401,"twenty":-9.881942,"median":-1.218535,"eighty":-0.723828,"marketCap":13160208},{"date":"2024-05-31","current":-0.67791,"twenty":-9.781214,"median":-1.215082,"eighty":-0.721304,"marketCap":13016381},{"date":"2024-06-07","current":-0.62173,"twenty":-9.713616,"median":-1.20985,"eighty":-0.718891,"marketCap":11937675},{"date":"2024-06-14","current":-0.575014,"twenty":-9.695879,"median":-1.208105,"eighty":-0.715401,"marketCap":11040701},{"date":"2024-06-21","current":-0.537432,"twenty":-9.677786,"median":-1.203101,"eighty":-0.711689,"marketCap":10319087},{"date":"2024-06-28","current":-0.514882,"twenty":-9.677786,"median":-1.202032,"eighty":-0.703794,"marketCap":9886118},{"date":"2024-07-05","current":-0.432388,"twenty":-9.653337,"median":-1.201796,"eighty":-0.699245,"marketCap":8302174},{"date":"2024-07-12","current":-0.511124,"twenty":-9.514792,"median":-1.195069,"eighty":-0.694483,"marketCap":9813957},{"date":"2024-07-15","current":-0.546827,"twenty":-9.474043,"median":-1.194248,"eighty":-0.694339,"marketCap":10499490},{"date":"2024-08-02","current":-0.514882,"twenty":-9.433295,"median":-1.193294,"eighty":-0.694166,"marketCap":9886118},{"date":"2024-08-09","current":-0.484816,"twenty":-9.266226,"median":-1.189983,"eighty":-0.690006,"marketCap":9308827},{"date":"2024-08-16","current":-0.482846,"twenty":-8.807452,"median":-1.186146,"eighty":-0.683019,"marketCap":8875858},{"date":"2024-08-23","current":-0.556281,"twenty":-8.539634,"median":-1.181258,"eighty":-0.67791,"marketCap":10225775},{"date":"2024-08-30","current":-0.562981,"twenty":-8.518548,"median":-1.18081,"eighty":-0.674691,"marketCap":10348933},{"date":"2024-09-06","current":-0.552221,"twenty":-8.490434,"median":-1.177036,"eighty":-0.670336,"marketCap":10151135},{"date":"2024-09-13","current":-0.487254,"twenty":-8.413121,"median":-1.169079,"eighty":-0.658277,"marketCap":8956884},{"date":"2024-09-20","current":-0.471134,"twenty":-8.314722,"median":-1.157566,"eighty":-0.652769,"marketCap":8660560},{"date":"2024-09-27","current":-0.466951,"twenty":-8.288616,"median":-1.152978,"eighty":-0.645274,"marketCap":8583680},{"date":"2024-10-04","current":-0.515677,"twenty":-8.215822,"median":-1.145645,"eighty":-0.643523,"marketCap":9479368},{"date":"2024-10-11","current":-0.527858,"twenty":-8.08981,"median":-1.143909,"eighty":-0.63691,"marketCap":9703291},{"date":"2024-10-18","current":-0.954205,"twenty":-7.977354,"median":-1.141931,"eighty":-0.63691,"marketCap":17540564},{"date":"2024-10-25","current":-1.023233,"twenty":-7.843812,"median":-1.140988,"eighty":-0.63754,"marketCap":18809456},{"date":"2024-10-31","current":-10.125098,"twenty":-8.103867,"median":-1.141931,"eighty":-0.637913,"marketCap":186123418},{"date":"2024-11-08","current":-10.161651,"twenty":-8.441235,"median":-1.143511,"eighty":-0.640228,"marketCap":186795344},{"date":"2024-11-15","current":-8.626437,"twenty":-8.609076,"median":-1.145645,"eighty":-0.643523,"marketCap":158574465},{"date":"2024-11-22","current":-6.902906,"twenty":-8.539634,"median":-1.151436,"eighty":-0.643542,"marketCap":135057065},{"date":"2024-11-29","current":-10.028102,"twenty":-8.539634,"median":-1.154747,"eighty":-0.643619,"marketCap":196202304},{"date":"2024-12-06","current":-9.375588,"twenty":-9.351798,"median":-1.166315,"eighty":-0.644323,"marketCap":183435716},{"date":"2024-12-13","current":-11.127072,"twenty":-9.540255,"median":-1.171959,"eighty":-0.644323,"marketCap":217703926},{"date":"2024-12-20","current":-10.852329,"twenty":-9.649913,"median":-1.178842,"eighty":-0.645611,"marketCap":212328521},{"date":"2024-12-27","current":-10.508901,"twenty":-9.689253,"median":-1.181258,"eighty":-0.646483,"marketCap":205609264},{"date":"2025-01-03","current":-11.298786,"twenty":-9.825314,"median":-1.181258,"eighty":-0.647449,"marketCap":221063555},{"date":"2025-01-10","current":-10.646272,"twenty":-10.023037,"median":-1.185285,"eighty":-0.648465,"marketCap":208296967},{"date":"2025-01-17","current":-9.478617,"twenty":-10.023037,"median":-1.188991,"eighty":-0.649543,"marketCap":185451493},{"date":"2025-01-24","current":-9.719016,"twenty":-10.007201,"median":-1.191902,"eighty":-0.651383,"marketCap":190154973},{"date":"2025-01-31","current":-6.59382,"twenty":-9.945931,"median":-1.19589,"eighty":-0.656956,"marketCap":129009734},{"date":"2025-02-07","current":-8.345304,"twenty":-9.830222,"median":-1.201839,"eighty":-0.657186,"marketCap":163277945},{"date":"2025-02-14","current":-7.658447,"twenty":-9.80081,"median":-1.203101,"eighty":-0.657672,"marketCap":149839431},{"date":"2025-02-21","current":-11.557305,"twenty":-9.832676,"median":-1.208105,"eighty":-0.657672,"marketCap":226121551},{"date":"2025-02-28","current":-8.295734,"twenty":-9.832676,"median":-1.212199,"eighty":-0.659184,"marketCap":162308107},{"date":"2025-03-07","current":-7.480342,"twenty":-9.820406,"median":-1.215085,"eighty":-0.662931,"marketCap":146354746},{"date":"2025-03-14","current":-7.799408,"twenty":-9.722425,"median":-1.220769,"eighty":-0.663566,"marketCap":152597365},{"date":"2025-03-21","current":-8.579349,"twenty":-9.719016,"median":-1.224571,"eighty":-0.670336,"marketCap":167857102},{"date":"2025-03-28","current":-8.40209,"twenty":-9.700402,"median":-1.230698,"eighty":-0.670336,"marketCap":164388980},{"date":"2025-04-04","current":-5.335216,"twenty":-9.686466,"median":-1.234683,"eighty":-0.670336,"marketCap":146824541},{"date":"2025-04-11","current":-5.024558,"twenty":-9.677786,"median":-1.246122,"eighty":-0.671169,"marketCap":138275264},{"date":"2025-04-17","current":-5.348723,"twenty":-9.677786,"median":-1.251318,"eighty":-0.675865,"marketCap":147196249},{"date":"2025-04-25","current":-6.105108,"twenty":-9.655822,"median":-1.261975,"eighty":-0.677237,"marketCap":168011880},{"date":"2025-05-02","current":-6.051081,"twenty":-9.650331,"median":-1.263712,"eighty":-0.677325,"marketCap":166525049},{"date":"2025-05-09","current":-5.672888,"twenty":-9.649997,"median":-1.269047,"eighty":-0.677795,"marketCap":156117234},{"date":"2025-05-16","current":-4.12907,"twenty":-9.649913,"median":-1.275205,"eighty":-0.67791,"marketCap":150913326},{"date":"2025-05-23","current":-3.742605,"twenty":-9.622773,"median":-1.277009,"eighty":-0.67791,"marketCap":136788433},{"date":"2025-05-30","current":-4.230771,"twenty":-9.615988,"median":-1.27716,"eighty":-0.679079,"marketCap":154630403},{"date":"2025-06-06","current":-3.986688,"twenty":-9.615988,"median":-1.281039,"eighty":-0.681344,"marketCap":145709418},{"date":"2025-06-13","current":-3.884987,"twenty":-9.579719,"median":-1.288108,"eighty":-0.683019,"marketCap":141992341},{"date":"2025-06-20","current":-3.457842,"twenty":-9.549426,"median":-1.293612,"eighty":-0.684245,"marketCap":126380618},{"date":"2025-06-27","current":-3.356141,"twenty":-9.5156,"median":-1.29788,"eighty":-0.686761,"marketCap":122663541},{"date":"2025-07-03","current":-3.844307,"twenty":-9.478617,"median":-1.299848,"eighty":-0.688871,"marketCap":140505510},{"date":"2025-07-11","current":-4.068049,"twenty":-9.478617,"median":-1.307438,"eighty":-0.689433,"marketCap":148683080},{"date":"2025-07-18","current":-3.864647,"twenty":-9.46488,"median":-1.318029,"eighty":-0.690751,"marketCap":141248926},{"date":"2025-07-25","current":-3.762946,"twenty":-9.409931,"median":-1.334256,"eighty":-0.691557,"marketCap":137531849},{"date":"2025-08-01","current":-3.213759,"twenty":-9.403062,"median":-1.344924,"eighty":-0.692413,"marketCap":117459633},{"date":"2025-08-08","current":-3.152738,"twenty":-9.375588,"median":-1.355762,"eighty":-0.694003,"marketCap":115229387},{"date":"2025-08-15","current":-3.070082,"twenty":-9.37083,"median":-1.368174,"eighty":-0.694331,"marketCap":127423445},{"date":"2025-08-22","current":-3.016221,"twenty":-9.349687,"median":-1.382337,"eighty":-0.69434,"marketCap":125187946},{"date":"2025-08-29","current":-3.30348,"twenty":-9.316493,"median":-1.389174,"eighty":-0.694483,"marketCap":137110608},{"date":"2025-09-05","current":-3.070082,"twenty":-9.217483,"median":-1.413215,"eighty":-0.695004,"marketCap":127423445},{"date":"2025-09-12","current":-3.016221,"twenty":-9.209178,"median":-1.458577,"eighty":-0.695269,"marketCap":125187946},{"date":"2025-09-19","current":-2.764869,"twenty":-9.135188,"median":-1.510053,"eighty":-0.696637,"marketCap":114755617},{"date":"2025-09-26","current":-2.782823,"twenty":-9.135188,"median":-1.547617,"eighty":-0.698503,"marketCap":115500784},{"date":"2025-10-03","current":-2.944406,"twenty":-8.845753,"median":-1.686517,"eighty":-0.702215,"marketCap":122207281},{"date":"2025-10-10","current":-2.980313,"twenty":-8.79206,"median":-1.842628,"eighty":-0.70301,"marketCap":123697614},{"date":"2025-10-17","current":-2.711008,"twenty":-8.756608,"median":-1.87675,"eighty":-0.70301,"marketCap":112520118},{"date":"2025-10-24","current":-2.746915,"twenty":-8.626437,"median":-1.953527,"eighty":-0.704971,"marketCap":114010451},{"date":"2025-10-31","current":-2.62124,"twenty":-8.525577,"median":-1.962058,"eighty":-0.707658,"marketCap":108794287},{"date":"2025-11-07","current":-2.675101,"twenty":-8.443903,"median":-2.030303,"eighty":-0.710345,"marketCap":111029786},{"date":"2025-11-14","current":-2.872591,"twenty":-8.40209,"median":-2.030303,"eighty":-0.710345,"marketCap":119226616},{"date":"2025-11-21","current":-2.413453,"twenty":-8.32926,"median":-2.030303,"eighty":-0.710345,"marketCap":115018218},{"date":"2025-11-28","current":-2.397679,"twenty":-8.179359,"median":-2.030303,"eighty":-0.710345,"marketCap":114266465},{"date":"2025-12-05","current":-2.381905,"twenty":-8.110112,"median":-2.064426,"eighty":-0.713479,"marketCap":113514712},{"date":"2025-12-12","current":-3.747701,"twenty":-8.084298,"median":-2.149732,"eighty":-0.714672,"marketCap":178604634},{"date":"2025-12-19","current":-4.10404,"twenty":-8.056808,"median":-2.200917,"eighty":-0.714734,"marketCap":195586714},{"date":"2025-12-26","current":-4.05489,"twenty":-8.015613,"median":-2.200917,"eighty":-0.714734,"marketCap":193244358},{"date":"2026-01-02","current":-5.883801,"twenty":-7.916734,"median":-2.200917,"eighty":-0.714734,"marketCap":280404994},{"date":"2026-01-09","current":-4.793145,"twenty":-7.800301,"median":-2.200917,"eighty":-0.714734,"marketCap":228427483},{"date":"2026-01-16","current":-4.735742,"twenty":-7.775213,"median":-2.200917,"eighty":-0.714734,"marketCap":225691824},{"date":"2026-01-23","current":-5.166265,"twenty":-7.638936,"median":-2.200917,"eighty":-0.714734,"marketCap":246209263},{"date":"2026-01-30","current":-4.506131,"twenty":-7.482348,"median":-2.200917,"eighty":-0.714734,"marketCap":214749190},{"date":"2026-02-06","current":-4.534832,"twenty":-7.344788,"median":-2.200917,"eighty":-0.714734,"marketCap":216117019},{"date":"2026-02-13","current":-4.707041,"twenty":-7.183132,"median":-2.200917,"eighty":-0.714734,"marketCap":224323995},{"date":"2026-02-20","current":-4.994056,"twenty":-7.133933,"median":-2.200917,"eighty":-0.714734,"marketCap":238002287},{"date":"2026-02-27","current":-5.998607,"twenty":-7.033214,"median":-2.200917,"eighty":-0.714734,"marketCap":285876311},{"date":"2026-03-06","current":-5.424578,"twenty":-6.933272,"median":-2.200917,"eighty":-0.714734,"marketCap":258519726},{"date":"2026-03-13","current":-5.711592,"twenty":-6.831707,"median":-2.200917,"eighty":-0.714734,"marketCap":272198018},{"date":"2026-03-20","current":-5.252369,"twenty":-6.772324,"median":-2.200917,"eighty":-0.714734,"marketCap":250312750},{"date":"2026-03-27","current":-5.756175,"twenty":-6.67708,"median":-2.200917,"eighty":-0.714734,"marketCap":277788339},{"date":"2026-04-02","current":-6.391826,"twenty":-6.641938,"median":-2.200917,"eighty":-0.714734,"marketCap":308464352},{"date":"2026-04-10","current":-5.968059,"twenty":-6.53651,"median":-2.200917,"eighty":-0.714734,"marketCap":288013676},{"date":"2026-04-17","current":-6.003373,"twenty":-6.358226,"median":-2.200917,"eighty":-0.714734,"marketCap":289717899},{"date":"2026-04-24","current":-6.816794,"twenty":-6.335324,"median":-2.200917,"eighty":-0.714734,"marketCap":328972927},{"date":"2026-05-01","current":-6.675513,"twenty":-6.335324,"median":-2.200917,"eighty":-0.714734,"marketCap":322154835},{"date":"2026-05-08","current":-7.028715,"twenty":-6.335324,"median":-2.200917,"eighty":-0.714734,"marketCap":339200065},{"date":"2026-05-15","current":-6.220122,"twenty":-6.321198,"median":-2.200917,"eighty":-0.714734,"marketCap":316985466},{"date":"2026-05-22","current":-5.818824,"twenty":-6.176068,"median":-2.200917,"eighty":-0.714734,"marketCap":296534791},{"date":"2026-05-29","current":-5.919148,"twenty":-6.105108,"median":-2.192386,"eighty":-0.714713,"marketCap":301647460},{"date":"2026-06-05","current":-5.551292,"twenty":-6.043645,"median":-2.200917,"eighty":-0.714734,"marketCap":282901008},{"date":"2026-06-12","current":-5.584733,"twenty":-6.000513,"median":-2.200917,"eighty":-0.714734,"marketCap":284605230},{"date":"2026-06-18","current":-5.618175,"twenty":-5.932745,"median":-2.200917,"eighty":-0.714734,"marketCap":286309453},{"date":"2026-06-26","current":-6.253564,"twenty":-5.927306,"median":-2.192386,"eighty":-0.714713,"marketCap":318689689},{"date":"2026-07-02","current":-6.487654,"twenty":-5.927306,"median":-2.192386,"eighty":-0.714713,"marketCap":330619250},{"date":"2026-07-10","current":-6.822069,"twenty":-5.927306,"median":-2.192386,"eighty":-0.714713,"marketCap":347661479},{"date":"2026-07-17","current":-6.721745,"twenty":-5.927306,"median":-2.192386,"eighty":-0.714713,"marketCap":342548810},{"date":"2026-07-24","current":-7.791873,"twenty":-5.927306,"median":-2.192386,"eighty":-0.714713,"marketCap":397083945},{"date":"2026-07-31","current":-8.743162,"twenty":-5.918521,"median":-2.183855,"eighty":-0.714693,"marketCap":445562830},{"date":"2026-08-07","current":-9.241675,"twenty":-5.918521,"median":-2.183855,"eighty":-0.714693,"marketCap":470967728},{"date":"2026-08-14","current":-7.23651,"twenty":-5.918521,"median":-2.183855,"eighty":-0.714693,"marketCap":438800292},{"date":"2026-08-21","current":-7.056348,"twenty":-5.918521,"median":-2.183855,"eighty":-0.714693,"marketCap":427875803},{"date":"2026-08-28","current":-7.416672,"twenty":-5.918521,"median":-2.183855,"eighty":-0.714693,"marketCap":449724780},{"date":"2026-08-31","current":-7.23651,"twenty":-5.918521,"median":-2.183855,"eighty":-0.714693,"marketCap":438800292}],"updateTime":1788276750125},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IKT\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648636551","title":"Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648636551","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648636551?lang=en_us&edition=fundamental","pubTime":"2026-07-03 04:01","pubTimestamp":1783022460,"startTime":"0","endTime":"0","summary":"WILMINGTON, Del., July  02, 2026  (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced that the Company granted non-qualified stock options to p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/02/3321544/0/en/Inhibikase-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647373249","title":"Inhibikase Shareholders Approve Governance and Compensation Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2647373249","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647373249?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:32","pubTimestamp":1782729131,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics ( ($IKT) ) has issued an announcement. At its annual meeting on June 26, 2026, Inhibikase Therapeutics’ stockholders approv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inhibikase-shareholders-approve-governance-and-compensation-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inhibikase-shareholders-approve-governance-and-compensation-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647378941","title":"Inhibikase Therapeutics Holds Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2647378941","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647378941?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:06","pubTimestamp":1782727581,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics holds annual shareholder meetingInhibikase Therapeutics held its annual shareholder meeting on June 26, 2026.Shareholders authorized an amendment to the 2020 Equity Incentive P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL5b4Tfx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642425232","title":"Inhibikase Therapeutics Inc : Oppenheimer Initiates Coverage With Outperform Rating and Target Price $5","url":"https://stock-news.laohu8.com/highlight/detail?id=2642425232","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642425232?lang=en_us&edition=fundamental","pubTime":"2026-06-10 20:22","pubTimestamp":1781094120,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nFWN42I104:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642423147","title":"Inhibikase Therapeutics initiated with an Outperform at Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2642423147","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642423147?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:34","pubTimestamp":1781091299,"startTime":"0","endTime":"0","summary":"Oppenheimer initiated coverage of Inhibikase Therapeutics (IKT) with an Outperform rating and $5 price target Inhibikase is developing IKT-001, an ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inhibikase-therapeutics-initiated-with-an-outperform-at-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inhibikase-therapeutics-initiated-with-an-outperform-at-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IKT","OPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642895428","title":"Oppenheimer Initiates Inhibikase Therapeutics at Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2642895428","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642895428?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:53","pubTimestamp":1781088838,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics (IKT) has an average rating of buy and mean price target of $5.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638515299","title":"Inhibikase Therapeutics: Buy Rating Reiterated on Advancing Phase 3 PAH Program and Robust IP, Price Target Maintained at $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2638515299","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638515299?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:36","pubTimestamp":1779791783,"startTime":"0","endTime":"0","summary":"In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Inhibikase Therapeutics, with a price target of $8.00. Ra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/inhibikase-therapeutics-buy-rating-reiterated-on-advancing-phase-3-pah-program-and-robust-ip-price-target-maintained-at-8-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/inhibikase-therapeutics-buy-rating-reiterated-on-advancing-phase-3-pah-program-and-robust-ip-price-target-maintained-at-8-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IKT","IP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635545066","title":"LifeSci Capital Keeps Their Buy Rating on Inhibikase Therapeutics (IKT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635545066","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635545066?lang=en_us&edition=fundamental","pubTime":"2026-05-16 22:35","pubTimestamp":1778942123,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Gaurav Maini maintained a Buy rating on Inhibikase Therapeutics today and set a price target of $5.00. According to TipRank...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-keeps-their-buy-rating-on-inhibikase-therapeutics-ikt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-keeps-their-buy-rating-on-inhibikase-therapeutics-ikt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635080103","title":"Analysts Are Bullish on These Healthcare Stocks: Milestone Scientific (MLSS), Inhibikase Therapeutics (IKT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635080103","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635080103?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:30","pubTimestamp":1778851818,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Milestone Scientific (MLSS), Inhibikase Therapeutics...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-milestone-scientific-mlss-inhibikase-therapeutics-ikt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-milestone-scientific-mlss-inhibikase-therapeutics-ikt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4581","IKT","BK4082","BLSX","BK4585","BK4588","LU0029874061.USD","MLSS","XBI","BK4139","BK4137","LU0128526141.USD","BLSG","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635286882","title":"Inhibikase Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635286882","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635286882?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:40","pubTimestamp":1778618407,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryInhibikase Therapeutics Inc IKT.OQ reported a quarterly adjusted loss of 10 cents per share for the quarter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P34F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635228335","title":"Inhibikase Therapeutics Q1 EPS $(0.10) Beats $(0.13) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635228335","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635228335?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:37","pubTimestamp":1778618262,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics (NASDAQ:IKT) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 33.33 percent increase over losses of $(0.15) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52507945/inhibikase-therapeutics-q1-eps-0-10-beats-0-13-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Inhibikase Therapeutics Q1 EPS $(0.10) Beats $(0.13) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635298242","title":"Inhibikase Therapeutics Announces First Quarter 2026 Financial Results and Highlights Recent Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2635298242","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635298242?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:01","pubTimestamp":1778616061,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA7QL5DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635246470","title":"Inhibikase Advances IKT-001 Into Adaptive Phase 3 Trial for Pulmonary Arterial Hypertension","url":"https://stock-news.laohu8.com/highlight/detail?id=2635246470","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635246470?lang=en_us&edition=fundamental","pubTime":"2026-05-13 00:31","pubTimestamp":1778603508,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics, Inc. ($IKT) announced an update on their ongoing clinical study. Inhibikase Therapeutics has launched a late-stage trial t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inhibikase-advances-ikt-001-into-adaptive-phase-3-trial-for-pulmonary-arterial-hypertension?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inhibikase-advances-ikt-001-into-adaptive-phase-3-trial-for-pulmonary-arterial-hypertension?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633458227","title":"Inhibikase Therapeutics Inc  expected to post a loss of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633458227","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633458227?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:21","pubTimestamp":1778239268,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics Inc  expected to post a loss of11cents a share - Earnings Preview Inhibikase Therapeutics Inc IKT.OQ IKT.O is expected to  show no change in quarterly revenue when it reports  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L13U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629751487","title":"Inhibikase Therapeutics announces annual shareholder meeting webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2629751487","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629751487?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:06","pubTimestamp":1776715601,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics scheduled 2026 annual shareholder meeting for June 26, 2026, to be held virtually.Shareholders will vote to elect two Class III directors: Arvind Kush, Dennis Berman.Ballot includes ratification of CohnReznick as independent auditor for fiscal 2026.Items include charter amendment to limit liability for certain officers, subject to stockholder approval.Meeting will also vote on increasing 2020 equity plan share reserve by 3,000,000 shares, executive pay advisory vote, preferred frequency for future pay votes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inhibikase Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDLjkpVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626592110","title":"Buy Rating on IKT-001: De-Risked Late-Stage PAH Program with Adaptive Phase 3 Design and Solid Financial Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2626592110","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626592110?lang=en_us&edition=fundamental","pubTime":"2026-04-09 02:55","pubTimestamp":1775674523,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Jason McCarthy reiterated a Buy rating on Inhibikase Therapeutics yesterday and set a price target of $8.00. Jason McCarthy has...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-ikt-001-de-risked-late-stage-pah-program-with-adaptive-phase-3-design-and-solid-financial-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-ikt-001-de-risked-late-stage-pah-program-with-adaptive-phase-3-design-and-solid-financial-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625910686","title":"Inhibikase Therapeutics: Phase 3 IKT-001 PAH Program and De-Risked Imatinib-Based Efficacy Drive Buy Rating and $8 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2625910686","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625910686?lang=en_us&edition=fundamental","pubTime":"2026-04-08 18:16","pubTimestamp":1775643382,"startTime":"0","endTime":"0","summary":"Analyst Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Inhibikase Therapeutics and keeping the price target at $8.00. Ram Selvaraju ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/inhibikase-therapeutics-phase-3-ikt-001-pah-program-and-de-risked-imatinib-based-efficacy-drive-buy-rating-and-8-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/inhibikase-therapeutics-phase-3-ikt-001-pah-program-and-de-risked-imatinib-based-efficacy-drive-buy-rating-and-8-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625205953","title":"Inhibikase Begins Pivotal Phase 3 Trial in PAH","url":"https://stock-news.laohu8.com/highlight/detail?id=2625205953","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625205953?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:54","pubTimestamp":1775566474,"startTime":"0","endTime":"0","summary":"An announcement from Inhibikase Therapeutics ( ($IKT) ) is now available. On April 7, 2026, Inhibikase Therapeutics announced it had enrolled the f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inhibikase-begins-pivotal-phase-3-trial-in-pah?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inhibikase-begins-pivotal-phase-3-trial-in-pah?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625893013","title":"Inhibikase enrolls first patient in Phase 3 IMPROVE-PAH trial for IKT-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2625893013","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625893013?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:06","pubTimestamp":1775563569,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics enrolled first patient in IMPROVE-PAH, a global Phase 3 study of oral PAH candidate IKT-001.Results have not been presented; trial is designed to generate pivotal data to support a potential NDA filing.Study will assess whether IKT-001 can improve pulmonary blood flow function, physical capacity, and disease progression measures versus placebo.Program positions IKT-001 as a reformulated approach to imatinib intended to reduce gastrointestinal side effects seen with the older drug.Trial is planned for up to 180 sites worldwide, using an adaptive design with two sequential parts covering about 486 patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inhibikase Therapeutics Inc. published the original content u","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL6JGtws:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625303479","title":"Inhibikase Therapeutics Announces Enrollment of First Patient in Improve-Pah Global Phase 3 Study of Ikt-001 in the Treatment of Pulmonary Arterial Hypertension","url":"https://stock-news.laohu8.com/highlight/detail?id=2625303479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625303479?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:00","pubTimestamp":1775563202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nTUA4QCJHF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IKT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}]}}